{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:17Z","timestamp":1791996077323,"version":"4.4.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203453","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T17:49:34Z","timestamp":1536256174000},"page":"e0203453","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus"],"prefix":"10.1371","volume":"13","author":[{"given":"Atsushi","family":"Komoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Maiguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9758-4791","authenticated-orcid":true,"given":"Yuto","family":"Haruki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1086\/502522","article-title":"The impact of methicillin resistance in <italic>Staphylococcus aureus<\/italic> bacteremia on patient outcomes: mortality, length of stay, and hospital charges","volume":"26","author":"SE Cosgrove","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diagmicrobio.2005.02.007","article-title":"Clinical and economic impact of methicillin resistance in patients with <italic>Staphylococcus aureus<\/italic> bacteremia","volume":"52","author":"TP Lodise","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1128\/AAC.00757-12","article-title":"Effect of reduced vancomycin susceptibility on clinical and economic outcomes in <italic>Staphylococcus aureus<\/italic> bacteremia","volume":"56","author":"JH Han","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.1086\/519471","article-title":"Alternatives to vancomycin for the treatment of methicillin resistant <italic>Staphylococcus aureus<\/italic> infections","volume":"45","author":"ST Micek","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with <italic>Staphylococcus aureus<\/italic> lower respiratory tract infections","volume":"43","author":"PA Moise-Broder","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can&apos;t get there from here","volume":"52","author":"N Patel","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"M Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","article-title":"A retrospective study of possible renal toxicity in patients with health care associated methicillin-resistant <italic>Staphylococcus aureus<\/italic> pneumonia treated with vancomycin","volume":"29","author":"MN Jeffres","year":"2007","journal-title":"Clin Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"T P Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10156-013-0599-4","article-title":"Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring","volume":"19","author":"K Matsumoto","year":"2013","journal-title":"J. Infect. Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000440607","article-title":"Safety and outcome of pharmacy-led vancomycin dosing and monitoring","volume":"61","author":"H Momattin","year":"2015","journal-title":"Chemotherapy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijantimicag.2011.08.017","article-title":"Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study","volume":"39","author":"J Li","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/IDR.S109485","article-title":"Pharmacist-managed dose adjustment feedback using therapeutic drug monitoring of vancomycin was useful for patients with methicillin-resistant Staphylococcus aureus infections: a single institution experience","volume":"9","author":"R Hirano","year":"2016","journal-title":"Infect Drug Resist"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00007691-199804000-00003","article-title":"Population pharmacokinetics of vancomycin in Japanese adult patients","volume":"20","author":"M Yasuhara","year":"1998","journal-title":"Ther Drug Monit"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2710.2008.01016.x","article-title":"Population pharmacokinetic analysis of vancomycin in patients with gram-positive infections and the influence of infectious disease type","volume":"34","author":"M Yamamoto","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"ref16","first-page":"221","article-title":"Evaluation of Predictability for the Initial Dose Setting of Vancomycin by the Population Mean Method","volume":"23","author":"A Tanaka","year":"2006","journal-title":"The Japanese Journal of TDM"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"H Quan","year":"2011","journal-title":"Am J Epidemiol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections","volume":"140","author":"DL Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cid\/cir124","article-title":"Impact of vancomycin exposure on outcomes in patients with methicillin-resistant <italic>Staphylococcus aureus<\/italic> bacteremia: support for consensus guidelines suggested targets","volume":"52","author":"R Kullar","year":"2011","journal-title":"Clin Infect Dis"},{"key":"ref20","first-page":"997","article-title":"Bactericidal activity of vancomycin against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"40","author":"Y Aoki","year":"1992","journal-title":"Chemotherapy"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1128\/AAC.01536-10","article-title":"Vancomycin bactericidal activity as a predictor of 30-day mortality in patients with methicillin-resistant <italic>Staphylococcus aureus<\/italic> bacteremia","volume":"55","author":"M Miyazaki","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/cc13874","article-title":"Dose contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critical ill patients? Data from the multinational DAKI Study","volume":"18","author":"S Blot","year":"2014","journal-title":"Critical Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s40064-015-1146-9","article-title":"Optimization of time to initial vancomycin target trough improves clinical outcomes","volume":"4","author":"AP Cardile","year":"2015","journal-title":"Springerplus"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10156-010-0086-0","article-title":"Clinical characteristics of vancomycin minimum inhibitory concentration of 2 \u03bcg\/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia","volume":"17","author":"Y Takesue","year":"2011","journal-title":"J Infect Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ajic.2017.06.012","article-title":"Decreased mortality in patients prescribed vancomycin after implementation of antimicrobial stewardship program","volume":"45","author":"EL Conway","year":"2017","journal-title":"Am J Infect Control"},{"key":"ref26","first-page":"284","article-title":"Impact of pharmacist intervention on preventing nephrotoxicity from vancomycin","volume":"53","author":"N Masuda","year":"2015","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","author":"TP Lodise","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"SJ Van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"BP Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1093\/jac\/dkq373","article-title":"Importance of appropriate empirical antibiotic therapy for methicillin-resistant <italic>Staphylococcus aureus<\/italic> bacteraemia","volume":"65","author":"M Paul","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1177\/1060028015587900","article-title":"Evaluation of a Pharmacist-Directed Vancomycin Dosing and Monitoring Pilot Program at a Tertiary Academic Medical Center","volume":"49","author":"KA Marquis","year":"2015","journal-title":"Ann Pharmacother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillinresistant <italic>Staphylococcus aureus<\/italic> bacteremia","volume":"46","author":"A Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in <italic>Staphylococcus aureus<\/italic> bacteremia: incidence, characteristics of patients and outcome","volume":"38","author":"R Khatib","year":"2006","journal-title":"Scand J Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T13:53:39Z","timestamp":1589032419000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203453"}},"subtitle":[],"editor":[{"given":"Tara C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203453","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]}}}